¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Neonatal jaundice from breast milk inhibitor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® neonatal intensive care center ÇÑ±Û ½Å»ý¾Æ ÁýÁßÄ¡·á½Ç
¼³¸í   
  ¹Ì¼÷¾Æ³ª °¡»ç »óÅÂÀÇ Ãâ»ê¾Æ¸¦ ÁýÁßÀûÀ¸·Î º¸»ìÇǰí Ä¡·áÇϴ ±â°ü.
¿µ¹® milk ÇÑ±Û Á¥, ¿ìÀ¯
¼³¸í   
  1. ¹Ì¼÷ Æ÷À¯µ¿¹°ÀÇ ÀÚ¿¬½ÄǰÀÌ µÇ´Â Á£»ùÀÇ ¾×üºÐºñ¹°. ¾Æ¹ÌÀÇ Á¥»ù¿¡¼­ »ý¼º-ºÐºñµÇ´Â ¾×ü. °« Å¾ »õ³¢¸¦ ¾çÀ°Çϱâ À§ÇØ ¾î¹Ì°¡ »ý»êÇϴ ¿Ïº®ÇÑ ÀÚ¿¬¿µ¾ç½ÄǰÀ¸·Î, Ãâ»ê ÈĠóÀ½À¸·Î ³ª¿À´Â Á¥À» ÃÊÀ¯¶ó°í Çϸç, ¹éÇ÷±¸³ª Áö¹æ¸³À» Ç°°í À־ È²»öÀ» ¶ìÁö¸¸ ¸çÄ¥ Áö³ª¸é Èò ºû±òÀÇ Á¥À¸·Î º¯ÇÑ´Ù. ¾à 87%ÀÇ ¼öºÐ ¿Ü¿¡ Á¥´ç-Áö¹æ-´Ü¹éÁú-ºñŸ¹Î-¹«±âÁúÀ» ÇÔÀ¯ÇÏÁö¸¸, Ã¶-±¸¸®-ºñŸ¹Î C, DÀÇ ÇÔÀ¯·®Àº ³·¾Æ ÁÖÀÇÇÒ Çʿ䰡 ÀÖ´Ù.
¿µ¹® icterus, jaundice ÇÑ±Û È²´Þ
¼³¸í   
  Ç÷¾× Áß¿¡ ºô¸®·çºó ¾çÀÌ Áõ°¡ÇÏ¿© ÇǺΠ¹× Á¡¸·³» ´ãÁóÀÇ ÃàÀûÀ¸·Î È²»öÀ» ³ªÅ¸³»´Â º´Àû»óÅÂ. ºô¸®·çºóÀº ÀûÇ÷±¸¿¡ ÇÔÀ¯µÇ´Â Ç÷»ö¼ÒÀǠü³»¿¡¼­ÀÇ ´ë»ç»ê¹°À̸ç, °£ ¶Ç´Â ±× ¹ÛÀǠƯ¼öÇÑ ¼¼Æ÷ ¼Ó¿¡¼­ ¸¸µé¾îÁö°í ¾µ°³Áó ¼Ó¿¡ ÇÔÀ¯µÇ¾î ¹è¼³µÇ´Â ÀûȲ»ö »ö¼ÒÀÌ´Ù. ¿øÀÎÀº ´ÙÀ½°ú °°ÀÌ ¼ÂÀ¸·Î Å©°Ô ³ª´«´Ù. ¨ç Æó»ö¼º È²´Þ: ¾µ°³µ¹À̳ª Á¾¾ç µî¿¡ ÀÇÇÏ¿© ´ã°ü¿¡¼­ Àå°üÀ¸·Î À¯ÃâµÇ¾î¾ß ÇÒ ´ãÁóÀÌ ¾µ°³°üÀÇ Æó»ö¿¡ ÀÇÇÏ¿© À¯ÃâÀå¾Ö¸¦ ÀÏÀ¸Å² °æ¿ì. ¨è °£¼¼Æ÷¼º È²´Þ ¹× °£¼¼¾µ°³°ü¼º È²´Þ: °£¼¼Æ÷ÀÇ ±â´ÉÀå¾Ö¿¡ ÀÇÇÑ ´ãÁóºÐºñÀå¾Ö¸¦ ÀÏÀ¸Å°´Â °æ¿ì·Î ±Þ¼º°£¿°¿¡ ÀÇÇÏ¿© ´ëÇ¥µÇ´Â °Í. ¨é ¿ëÇ÷Ȳ´Þ: °úÀ×ÀÇ Ç÷±¸ ÆÄ±«·Î ÀÎÇÏ¿© ÀϾ´Â °ÍÀ¸·Î ÁַΠ¿ëÇ÷¼º ºóÇ÷ÀΠ°æ¿ì¿¡ ÀϾ´Â °ÍÀÌ ÀÖ´Ù. ¶Ç Áõ¼¼¸¦ °æÁß¿¡ µû¶ó ±¸º°Çϸé, Ä«Å¸¸£¼º È²´ÞÀº °æµµÀÇ Áõ¼¼ÀΠ°æ¿ìÀ̸ç, µÎÅë-±Çۨ ¿Ü¿¡ ¸Æ¹ÚÀÌ ´À·ÁÁö°í, ¶§·Î´Â ÇǺΰ¡ °¡·Á¿öÁø´Ù. ÁßÁõ È²´ÞÀº À§µ¶ÇÑ Áõ¼¼À̸ç, ¹ß¿­-°£ºÎºÐÀÇ ÅëÁõ, È¥¼ö µîÀ» º¼ ¼ö ÀÖ°í, ±Þ¼º °£À§ÃàÁõ-°£°æÈ­Áõ-°£¾Ï µîÀÇ °æ¿ì¿¡ º¼ ¼ö ÀÖ´Ù. 
¿µ¹® funnel breast ÇÑ±Û ¿À¸ñ°¡½¿, ´©µÎÈä
¼³¸í   
  ¾Õ°¡½¿ÀÇ Á߾Ӻΰ¡ ±ò´ë±â ¸ð¾çÀ¸·Î ÇÔ¸ôµÇ¾î Àִ °Í. ´ëºÎºÐ À¯Àü¼ºÀ¸·Î ½ÉÇÑ °æ¿ì¿¡´Â ½ÉÀåÀ̳ª ÇãÆÄ¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù. Àα¸ 300~400¸íÀÇ ½Å»ý¾Æ Áß 1¸íÀÌ ÀÌ Áúȯ¿¡ °É¸± ¼ö Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. º¸Åë ÀÌ Áõ»óÀ» °®°í Àִ »ç¶÷Àº ¸¶¸¥Ã¼ÇüÀ̰í Ã´ÃßÈĸ¸ µî ÀÚ¼¼ÀÇ ÀÌ»óÀ» µ¿¹ÝÇϴ °æ¿ì°¡ ¸¹´Ù. º¸Å렽Żý¾Æ±â, ¿µ¾Æ±â µî ¾î·Á¼­ºÎÅÍ ¾Ë°Ô µÇ¸ç, ±âÇüÀûÀΠ¸ð½À ¶§¹®¿¡ Çб³»ýȰÀ̳ª »çȸ»ýȰÀ» ÇÒ ¶§ ÁöÀåÀ» ¹ÞÀ» ¼öµµ ÀÖ´Ù. ³²ÀÚ¿¡°Ô ¸¹ÀÌ ¹ß»ýÇϰí, »ó±âµµÆó»ö-±â°üÁö¿¬È­Áõ°ú °ü·ÃµÇ¾î »ý±æ ¼öµµ ÀÖ´Ù. º¸ÅëÀÇ °æ¿ì Áõ»óÀÌ ¾øÁö¸¸, ½ÉÇÑ °æ¿ì ½ÉÆó±â´ÉÀÇ Àå¾Ö·Î ÀÎÇØ ¿îµ¿ÇÒ ¶§ ¼ûÀÌ Â÷°í, ¹Ýº¹µÇ´Â °¨±âÁõ»óÀÌ ÀÖÀ» ¼ö ÀÖ´Ù. ½Â¸ðÆÇ Å»Ãâ, Á¶±âÈïºÐÁõÈıºÀÌ ³ªÅ¸³ª´Â °æ¿ìµµ ÀÖ´Ù.
¿µ¹® fibrocystic disease of breast ÇÑ±Û À¯¹æ ¼¶À¯³¶º´
¼³¸í   
  Á¥À» »ý»êÇϴ Á¥»ù³»¿¡ ¿ÏµÎÄᠶǴ ūÄá Å©±âÀÇ °áÀýÀÌ ¹ß»ýÇϴ Áõ¼¼¸¦ Æ¯Â¡À¸·Î Çϴ º´. 30~50´ëÀÇ ºÎÀο¡°Ô ÈçÈ÷ ¹ß»ýÇϸç, ±× ´ëºÎºÐÀº ¾çÂÊ À¯¹æ¿¡ µ¿½Ã¿¡ ¹ß»ýÇÑ´Ù. ÀÌ·¯ÇÑ °áÀýÀº µÎ ¼Õ°¡¶ô »çÀÌ¿¡ ³¢¿ö ÃËÁøÇÒ ¶§´Â ºÐ¸íÇÏÁö¸¸, È亮À» ¼Õ¹Ù´ÚÀ¸·Î ´©¸£¸é ¸í·áÇÏÁö ¾ÊÀ» Á¤µµ·Î ºÎµå·¯¿î °ÍÀÌ ¸¹´Ù. ±× ¹ß»ý ¿øÀο¡´Â ¿©·¯ °¡Áö ¼³ÀÌ ¸¹Àºµ¥, Á¥»ùÁ¶Á÷¿¡ ´ëÇÑ ¸¸¼ºÀûÀΠÀÚ±ØÀÌ ÁÖ¿øÀÎÀ̶ó »ý°¢µÇ°í ÀÖÀ¸¸ç, ±ØÈ÷ ¼­¼­È÷ ÁøÇàÇϴ °æ°ú¸¦ ¹â´Â´Ù. Áø´ÜÀº ÃËÁø, ÃÊÀ½ÆÄÁø´Ü µîÀ¸·Î Çϸç, ¾Ï°ú °¨º°ÀÌ °ï¶õÇÒ ¶§´Â Á¶Á÷ÀÇ ÀϺθ¦ Ã¤ÃëÇÏ¿© °Ë»çÇϴ »ý°ËÀÌ ÀÌ¿ëµÇ±âµµ ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • breast milk jaundice
    ¸ðÀ¯È²´Þ
  • breast milk
    ¸ðÀ¯, ¾ö¸¶Á¥
  • angiotensin converting enzyme inhibitor
    ¾ØÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦
  • clotting inhibitor
    ÀÀ°í¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
  • competitive inhibitor
    °æÀï¾ïÁ¦Á¦
  • complement inhibitor
    º¸Ã¼¾ïÁ¦Á¦, µµ¿òü¾ïÁ¦Á¦
  • carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼Ò¾ïÁ¦Á¦
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • corrosion inhibitor
    ºÎ½Ä¾ïÁ¦Á¦
  • enzyme inhibitor
    È¿¼Ò¾ïÁ¦Á¦
  • inhibitor
    1. ¾ïÁ¦Á¦ 2. ¾ïÁ¦ÀÎÀÚ
  • mitotic inhibitor
    À¯»çºÐ¿­¾ïÁ¦Á¦
  • metabolic inhibitor
    ´ë»ç¾ïÁ¦Á¦
  • oocyte maturation inhibitor
    ³­ÀÚ¼º¼÷¾ïÁ¦ÀÎÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • jaundice
    Ȳ´Þ
  • inhibitor
    ¾ïÁ¦Á¦
  • selective serotonin reabsorption inhibitor
    ¼±Åü¼·ÎÅä´ÑÀçÈí¼ö¾ïÁ¦Á¦
  • inhibitor substance
    ¾ïÁ¦¹°Áú
  • milk fat
    ¿ìÀ¯Áö¹æ, À¯Áö¹æ
  • milk
    Á¥, ¿ìÀ¯
  • mature milk
    ¼º¼÷À¯
  • soy milk
    µÎÀ¯, ÄáÁ¥
  • milk tooth
    Á¥´Ï, À¯Ä¡
  • neonatal intensive care center
    ½Å»ý¾ÆÁýÁßÄ¡·á½Ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
  • neonatal infection
    °«³­¾Ö°¨¿°, ½Å»ý¾Æ°¨¿°
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á·ü
  • neonatal period
    ½Å»ý¾Æ±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • breast milk jaundice
    ¸ðÀ¯È²´Þ
  • breast milk
    ¸ðÀ¯, ¾ö¸¶Á¥, ¾î¹ÌÁ¥
  • carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼Ò¾ïÁ¦Á¦
  • clotting inhibitor
    ÀÀ°í¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
  • competitive inhibitor
    °æÀï¾ïÁ¦Á¦
  • complement inhibitor
    º¸Ã¼¾ïÁ¦Á¦, µµ¿òü¾ïÁ¦Á¦
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • corrosion inhibitor
    ºÎ½Ä¾ïÁ¦Á¦
  • enzyme inhibitor
    È¿¼Ò¾ïÁ¦Á¦
  • inhibitor
    ¾ïÁ¦Á¦
  • inhibitor substance
    ¾ïÁ¦¹°Áú
  • metabolic inhibitor
    ´ë»ç¾ïÁ¦Á¦
  • mitotic inhibitor
    Çٺп­¾ïÁ¦Á¦
  • oocyte maturation inhibitor
    ³­ÀÚ¼º¼÷¾ïÁ¦ÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accessory breast
    (µ¡Á¥)
  • areola of breast
    Á¥²ÉÆÇ
  • funnel breast
    ´©µÎÈä(שÔàýØ).
  • gargantuan breast
    ºñ´ë¼º À¯¹æ(ºñ´ë¼ºÀ¯¹æ).
  • gargantuan breast
    ºñ´ë¼º À¯¹æ(ÝþÓÞàõêáÛ®).
  • gathered breast
    À¯¹æ³ó¾ç(À¯¹æ³ó¾ç).
  • hysterical breast
    È÷½ºÅ׸®¼º À¯¹æ(½Å°æÅë).
  • pigeon breast
    ºñµÑ±â°¡½¿.
  • pigeon breast
    ºñµÑ±â°¡½¿
  • pigeon-breast deformity
    ºñµÑ±â°¡½¿¸ð¾ç(Ù¼åÆ)ÀÇ º¯Çü(ܨû¡)
  • acidified milk
    »ê¼ºÀ¯(ß«àõêá).
  • adapted milk
    ¼øÀÀÀ¯(â÷ëëêá).
  • albumin milk
    ¾ËºÎ¹ÎÀ¯.
  • galactopyra =milk fever
    À¯¿­(êáæð).
  • goat fever =goat s milk f.
    »ê¾çÀ¯¿­(ߣåÏêáæð).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • breast milk jaundice
  • neonatal jaundice
    ½Å»ý¾ÆÈ²´Þ.
  • breast milk
    ¸ðÀ¯(Ù½êá).
  • breast milk
    ¸ðÀ¯ (Ù½êá)
  • dry milk =dried milk
    ºÐÀ¯(ÝÏêá).
  • alloimmune neonatal thrombocytopenia=ANN
    µ¿Á¾¸é¿ª¼º½Å»ý¾ÆÇ÷¼ÒÆÇ°¨¼ÒÁõ
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü(ËàË×ËâË×ËÎËô).
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü(ãæßæä®ÞÝØÌëÒ).
  • eruptive neonatal angiomatosis
    ¹ßÁø¼º ½Å»ý¾Æ Ç÷°üÁ¾Áõ
  • isoimmune neonatal neutropenia
    ½Å»ý¾Æµ¿Á¾¸é¿ª¼º È£Áß±¸°¨¼Ò(Áõ).
  • neonatal
  • neonatal =neonate
    ½Å»ý¾Æ(ãæßæä®)ÀÇ, ½Å »ý¾Æ.
  • neonatal adnexal polyp
    ½Å»ý¾Æ ºÎ¼Ó±â ¿ëÁ¾
  • neonatal alloimmune thrombocytopenia=NAIT
    ½Å»ý¾Æµ¿Á¾¸é¿ªÇ÷¼ÒÆÇ °áÇÌÁõ
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷(~Þ¸úì).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Milk secreting cell
    Á¥ºÐºñ¼¼Æ÷
    [¿¾ ¿ë¾î] À¯¼¼Æ÷
  • Neonatal period
    ½Å»ý¾Æ±â
    [¿¾ ¿ë¾î] ½Å»ý¾Æ±â
  • Neonatal line
    ù¼ºÀå¼±
    [¿¾ ¿ë¾î] ½Å»ý¼±
  • Male breast
    ³²¼ºÁ¥
    [¿¾ ¿ë¾î] ³²¼ºÀ¯¹æ
  • Breast
    Á¥ [À¯¹æ]
    [¿¾ ¿ë¾î] À¯¹æ
  • Areola of breast
    Á¥²ÉÆÇ
    [¿¾ ¿ë¾î] À¯·û
  • Body of breast
    Á¥¸öÅë
    [¿¾ ¿ë¾î] À¯µÎü
  • Suspensory ligaments of breast
    Á¥»ù°ÉÀÌÀδë
    [¿¾ ¿ë¾î] À¯¹æÁ¦Àδë
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • milk intolerance
    Á£ °ÅºÎÁõ(ËÞÜúñø)
  • milk sugar
    À¯´ç(êáÓØ)
  • active site-directed irreversible inhibitor
    Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
  • Bowman-Birk inhibitor
    "º¸¿ì¸¸-¹÷Å© ÀúÇØÀÚ(îÁúªí­), º¸¿ì¸¸-¹÷Å© ÀúÇØÁ¦(îÁúªð¥)"
  • competitive inhibitor
    °æÇÕÀúÇØÁ¦(ÌæùêîÁúªð¥)
  • enzyme-inhibitor complex
    È¿¼Ò-ÀúÇØÁ¦ º¹ÇÕü (ý£áÈîÁúªð¥ÜÜùêô÷)
  • heme-controlled inhibitor
    Èû-Á¦¾î(ð¤åÙ) ÀúÇØÁ¦(îÁúªð¥)
  • inhibitor
    ÀúÇØÁ¦(îÁúªð¥)
  • inhibitor constant
    ÀúÇØÁ¦»ó¼ö(îÁúªð¥ßÈâ¦)
  • irreversible inhibitor
    ºñ°¡¿ª ÀúÇØÁ¦(ުʦæ½îÁúªð¥)
  • Kunitz inhibitor
    Äï´ÏÃ÷ ÀúÇØÁ¦(îÁúªð­)
  • mixed-type inhibitor
    È¥ÇÕÇü ÀúÇØÁ¦(ûèùêúþîÁúªð¥)
  • noncompetitive inhibitor
    ºñ°áÇÕ ÀúÇØÁ¦(ު̿ùêîÁúªðº)
  • ovulation inhibitor
    ¹è¶õ ÀúÇØÁ¦(ÛÉÕ°îÁúªð¥)
  • respiratory inhibitor
    È£Èí ÀúÇØÁ¦(îÁúªð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal jaundice
    ½Å»ý¾ÆÈ²´Þ
  • breast milk
    ¸ðÀ¯
  • inhibitor
    ¾ïÁ¦Á¦, ¾ïÁ¦¹°Áú, ¾ïÁ¦ÀÎÀÚ, ¾ïÁ¦½Å°æ, ¾ïÁ¦À¯ÀüÀÚ, ¾ïÁ¦¾à
  • neonatal
    ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á(·ü)
  • calcium, milk
    Ä®½·¿ìÀ¯
  • milk
    Á¥, ¿ìÀ¯, À¯
  • milk of calcium
    ¿ìÀ¯ÇüÄ®½·
  • milk of calcium bile
    ¿ìÀ¯ÇüÄ®½·´ãÁó
  • aberrant breast tissue
    ¹ÌÀÔÀ¯¹æÁ¶Á÷
  • breast
    °¡½¿, ÀüÈäºÎ, À¯¹æ
  • breast cancer
    À¯¹æ¾Ï
  • breast feeding
    ¸ðÀ¯¿µ¾ç
  • interventional breast ultrasound
    ÁßÀçÀûÀ¯¹æÃÊÀ½ÆÄ°Ë»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BPTI basic pancreatic trypsin inhibitor; basic polyvalent trypsin inhibitor; bovine pancreatic trypsin in...
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
BM Bachelor of Medicine; barium meal; basal medium; basal metabolism; basement membrane; basilar membra...
EBM electrophysiologic behavior modification; epidermal basement membrane; evidence-based medicine; expr...
MBC male breast cancer; maximal bladder capacity; maximal breathing capacity; metastatic breast cancer; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OJ Obstructive jaundice
EBM expressed breast milk
ACE inhibitor angiotensin converting enzyme inhibitor
CMPI Cow's Milk Protein Intolerance
CM Cow's milk
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • P59.3
    Neonatal jaundice from breast milk inhibitor
    ¸ðÀ¯ ¾ïÁ¦ÀÎÀÚ·Î ÀÎÇÑ ½Å»ý¾Æ Ȳ´Þ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • breast milk jaundice
    ¸ðÀ¯¼º Ȳ´Þ
    ¸ðÀ¯·Î Ű¿î ¾ÆÀÌ¿¡°Ô¼­ ºñÆ÷ÇÕ¼º ºô¸®·çºóÀÌ »ó½ÂµÈ »óÅ·μ­, glucuronyl transferaseÀÇ Æ÷ÇÕ È°µ¿À» ¾ïÁ¦ÇÏ´Â ¿ä¼ÒÀÇ Á¸Àç¿¡ ±âÀÎÇÑ´Ù.
  • acathetic jaundice
    ¹ü¶÷¼º Ȳ´Þ
    ºÐºñ¹°À» ´ã¾Æ µÑ ¼ö ¾ø°Ô µÇ´Â °£¼¼Æ÷ÀÇ º´ÀûÀÎ º¯È­¿¡ ±âÀÎÇϴ Ȳ´Þ.
  • acholuric jaundice
    ¹«ºô¸®·çºó´¢¼º Ȳ´Þ
    ½ÅÀåÀ¸·Î ¹èÃâÇÏÁö ¸øÇÏ´Â ºñÆ÷ÇÕ¼º ºô¸®·çºóÀÇ ³ôÀº Ä¡¸¦ °¡Áö°í ÀÖ°í, ºô¸®·çºó´¢ÁõÀ» ¼ö¹ÝÇÏÁö ¾Ê´Â Ȳ´Þ, ¿ëÇ÷ ÁúȯÀ̳ª ºñÆ÷ÇÕ¼º °úºô¸®·çºóÇ÷ÁõÀÇ ´Ù¸¥ Çü¿¡¼­ º¼ ¼ö ÀÖ´Ù.
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ ÀÀ°í °áÇÕü
  • black jaundice
    Èæ Ȳ´Þ
  • C1-esterase inhibitor
    C1-esterase ¾ïÁ¦ ¹°Áú
  • cell wall inhibitor
    ¼¼Æ÷ º® ÇÕ¼º ¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°í ÀÎÀÚ ¾ïÁ¦Á¦
  • collagenase inhibitor
    Äݶó°Ô³ªÁ¦ ¾ïÁ¦ ¹°Áú
  • cyclooxygenase inhibitor
    »çÀÌŬ·Î¿Á½ÃÁö³×ÀÌÁî ¾ïÁ¦Àç
  • dopa decarboxylase inhibitor
    µµÆÄ µ¥Ä«¸£º¹½Ç·¹À̽º ¾ïÁ¦ÀÚ
  • epidemic jaundice
    À¯Ç༺ Ȳ´Þ
  • hemapheic jaundice
    ¿ì·Îºô¸°¼º Ȳ´Þ
    µ¿ÀǾî=urobilin jaundice.
  • hematohepatogenous jaundice
    Ç÷¾×°£¼º Ȳ´Þ
  • jaundice due to biliary stasis
    ´ãÁó ¿ïü¼º Ȳ´Þ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
neonatal jaundice Icterus which can be accentuated by many factors including excessive haemolysis, sepsis, neonatal hepatitis or congenital atresia of the biliary system.
Synonym: physiologic icterus, jaundice of the newborn, neonatal jaundice, physiologic jaundice.
(05 Mar 2000)
jaundice, neonatal The jaundice sometimes seen in newborn infants. It is also called icterus neonatorum.
(12 Dec 1998)
anaemia, neonatal The mildest form of erythroblastosis foetalis in which anaemia is the chief manifestation.
(12 Dec 1998)
benign neonatal convulsions A familial, self-limited epilepsy, beginning at two or three days of age and resolving spontaneously by six months of age; autosomal dominant inheritance.
(05 Mar 2000)
Brazelton's Neonatal Behavioural Assessment Scale A scale used by obstetricians, paediatricians, and paediatric psychologists to assess the sensory, motor, emotional and physical development of the neonate, usually beginning at birth or in the first month of life.
(05 Mar 2000)
rate, neonatal mortality The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
mortality rate, neonatal The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
neonatal <paediatrics> Pertaining to the first four weeks after birth.
Origin: L. Natus = born
(18 Nov 1997)
neonatal abstinence syndrome <syndrome> Foetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
(12 Dec 1998)
neonatal anaemia <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells).
Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia.
(27 Sep 1997)
neonatal apoplexy Intracranial haemorrhage in newborn children.
(05 Mar 2000)
neonatal arthritis of foals Bacterial polyarthritis caused by umbilical infections by several bacterial species.
(05 Mar 2000)
neonatal calf diarrhoea virus One of two virus's causing neonatal calf diarrhoea; a reovirus-like virus is associated with disease in newborn calves, and a coronavirus is associated with disease in calves over 5 days of age.
(05 Mar 2000)
neonatal conjunctivitis Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is neisseria gonorrhoeae. The baby's eyes are contaminated during passage through the birth canal.
(12 Dec 1998)
neonatal death Death of a young, liveborn infant; classified as:
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inhibitor
    ¾ïÁ¦ÀÚ(¹°);¹ÝÀÀ¾ïÁ¦Á¦
  • neonatal
    ½Å»ý¾ÆÀÇ
  • jaundice
    Ȳ´Þ
  • jaundice
    Ȳ´Þ;Æí°ß;ºùÅü ±×·¯Áü
  • breast
    °¡½¿
  • breast-high
    °¡½¿±îÁö ³ôÀÌÀÇ
  • breast
    °¡½¿;ÈäºÎ;À¯¹æ;°¡½¿¿¡¹Þ´Ù;¹«¸¨¾²´Ù
  • breast stoke
    °³±¸¸®Çì¾ö
  • breast stroke
    °³±¸¸® Çì¾ö 6
  • breast wall
    (Á¦¹æÀÇ)È亮
  • breast wall
    È亮;Á¦¹æÀÇ È亮
  • chicken breast
    »õ°¡½¿
  • chimney breast
    ±¼¶ÒÀ̳ª º®³­·Î°¡ º®¿¡¼­ ¹æ¾ÈÀ¸·Î ³»¹Î ºÎºÐ
  • pigeon breast
    »õ°¡½¿
  • milk
    Á¥,¿ìÀ¯,À¯Á¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á